Las Vegas, NV -- (SBWIRE) -- 01/02/2014 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks: Cannabis Science Inc(OTCMKTS:CBIS), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), Affymax, Inc.(OTCMKTS:AFFY), Nortel Networks Corporation (USA)(OTCMKTS:NRTLQ).
Cannabis Science Inc(OTCMKTS:CBIS) ended higher 25.92% and complete the day at $0.0515. The total number of shares changed hands during the day was 28.55 million. After opening at $0.04, the stock hit as high as $0.05. However, it traded between $0.03 and $0.12 over the last twelve months. Cannabis Science, Inc. is a development-stage company. Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.
For How Long CBIS will Fight for Profitability? Read This Trend Analysis report
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) closed yesterday at $2.41, a +3.88% increase. Around 962,561 shares were traded, low from an-average trading volume of 1.48 million shares. The company is now valued at around $337.34 million. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
For How Long PVCT Gloss will Attract Investors? Find out via this report
Affymax, Inc.(OTCMKTS:AFFY) moved +2.55 percent higher at $0.780 and traded between $0.74 and $0.79 after opening the day at $0.76. Its performance over the last five days remained -3.11%, which stands at -8.24% for a month. Going back further than one month, 1-year performance after recent close was -2.55%.Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis.
For How Long AFFY Gloss will Attract Investors? Find out via this report
Nortel Networks Corporation (USA)(OTCMKTS:NRTLQ) shares fall, losing -6.90 percent to close at $0.0081. The stock is down around -6.9% this year and 35% for the last 12 months. Around 280,468 shares changed hands yesterday, lower from an-average trading volume of 681,061 shares. Nortel Networks Corporation does not have significant operations. Previously, it engaged in supplying networking products and solutions, including hardware, software, and services to service providers and enterprise customers worldwide.
Will NRTLQ Get Buyers Even After The Recent Rally? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)